ICSMA-25-336-01
·
Published 2025-12-02
·
View on CISA ICS-CERT ↗
Mirion Medical EC2 Software NMIS BioDose
CVSS 8.4
HIGH
Risk Summary
Successful exploitation of these vulnerabilities could allow an attacker to modify program executables, gain access to sensitive information, gain unauthorized access to the application, and execute arbitrary code.
Remediations
- Mirion Medical recommends users update to V23.0 or later. Users with an active support contract should update to the latest version through the software or users can contact Mirion Medical support directly.
Affected Vendors
Mirion Medical
Affected Products (1)
Mirion Medical
·
EC2 Software NMIS BioDose
<23.0
Affected Sectors
Healthcare and Public Health
Get alerted to advisories like this
OTWarden monitors CISA, BSI, Siemens, Rockwell and more — and emails you within 2 hours when your vendors are affected.
Start free trial Learn more